Alan M. Garber

Publications

• Cost-effectiveness of statins for primary cardiovascular prevention in chronic kidney disease. Erickson KF, Japa S, Owens DK, Chertow GM, Garber AM, Goldhaber-Fiebert JD. J Am Coll Cardiol. 2013; 61 (12): 1250-8
• An economic analysis of conservative management versus active treatment for men with localized prostate cancer. Perlroth DJ, Bhattacharya J, Goldman DP, Garber AM. J Natl Cancer Inst Monogr. 2012; 2012 (45): 250-7
• Cost-effectiveness of early colectomy with ileal pouch-anal anastamosis versus standard medical therapy in severe ulcerative colitis. Park KT, Tsai R, Perez F, Cipriano LE, Bass D, Garber AM. Ann Surg. 2012; 256 (1): 117-24
• Cost-effectiveness analysis of adjunct VSL#3 therapy versus standard medical therapy in pediatric ulcerative colitis. Park KT, Perez F, Tsai R, Honkanen A, Bass D, Garber A. J Pediatr Gastroenterol Nutr. 2011; 53 (5): 489-96
• Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation. Freeman JV, Zhu RP, Owens DK, Garber AM, Hutton DW, Go AS, Wang PJ, Turakhia MP. Ann Intern Med. 2011; 154 (1): 1-11
• How CER could pay for itself--insights from vertebral fracture treatments. Elshaug AG, Garber AM. N Engl J Med. 2011; 364 (15): 1390-3
• Individualized cost-effectiveness analysis. Ioannidis JP, Garber AM. PLoS Med. 2011; 8 (7): e1001058
• A cost-benefit analysis of preimplantation genetic diagnosis for carrier couples of cystic fibrosis. Davis LB, Champion SJ, Fair SO, Baker VL, Garber AM. Fertil Steril. 2010; 93 (6): 1793-804
• Correction to mikels et Al. (2010). Mikels JA, Löckenhoff CE, Maglio SJ, Goldstein MK, Garber A, Carstensen LL. J Exp Psychol Appl. 2010; 16 (2): 157
• Cost effectiveness of alternative imaging strategies for the diagnosis of small-bowel Crohn's disease. Levesque BG, Cipriano LE, Chang SL, Lee KK, Owens DK, Garber AM. Clin Gastroenterol Hepatol. 2010; 8 (3): 261-7, 267.e1-4
• Following your heart or your head: focusing on emotions versus information differentially influences the decisions of younger and older adults. Mikels JA, Löckenhoff CE, Maglio SJ, Goldstein MK, Garber A, Carstensen LL. J Exp Psychol Appl. 2010; 16 (1): 87-95
• Health outcomes and costs of community mitigation strategies for an influenza pandemic in the United States. Perlroth DJ, Glass RJ, Davey VJ, Cannon D, Garber AM, Owens DK. Clin Infect Dis. 2010; 50 (2): 165-74
• Incidental extracardiac findings at coronary CT: clinical and economic impact. Lee CI, Tsai EB, Sigal BM, Plevritis SK, Garber AM, Rubin GD. AJR Am J Roentgenol. 2010; 194 (6): 1531-8
• Modernizing device regulation. Garber AM, N Engl J Med. 2010; 362 (13): 1161-3
• Population strategies to decrease sodium intake and the burden of cardiovascular disease: a cost-effectiveness analysis. Smith-Spangler CM, Juusola JL, Enns EA, Owens DK, Garber AM. Ann Intern Med. 2010; 152 (8): 481-7, W170-3
• The potential impact of comparative effectiveness research on U.S. health care expenditures. Perlroth DJ, Goldman DP, Garber AM. Demography. 2010: 47 Suppl S173-90
• The role of costs in comparative effectiveness research. Garber AM, Sox HC. Health Aff (Millwood). 2010; 29 (10): 1805-11
• Effectiveness and Cost-Effectiveness of Expanded Antiviral Prophylaxis and Adjuvanted Vaccination Strategies for an Influenza A (H5N1) Pandemic. Khazeni N, Hutton DW, Garber AM, Owens DK. Ann Intern Med. 2009
• Effectiveness and Cost-Effectiveness of Vaccination Against Pandemic Influenza (H1N1) 2009. Khazeni N, Hutton DW, Garber AM, Hupert N, Owens DK. Ann Intern Med. 2009
• Effectiveness and cost-effectiveness of expanded antiviral prophylaxis and adjuvanted vaccination strategies for an influenza A (H5N1) pandemic. Khazeni N, Hutton DW, Garber AM, Owens DK. Ann Intern Med. 2009; 151 (12): 840-53
• Effectiveness and cost-effectiveness of vaccination against pandemic influenza (H1N1) 2009. Khazeni N, Hutton DW, Garber AM, Hupert N, Owens DK. Ann Intern Med. 2009; 151 (12): 829-39
• Laparoscopy in women with unexplained infertility: a cost-effectiveness analysis. Moayeri SE, Lee HC, Lathi RB, Westphal LM, Milki AA, Garber AM. Fertil Steril. 2009; 92 (2): 471-80
• The confirmatory trial in comparative-effectiveness research. Garber AM, Hlatky MA. N Engl J Med. 2009; 361 (15): 1498-9
• Toward a 21st-century health care system: recommendations for health care reform. Arrow K, Auerbach A, Bertko J, Brownlee S, Casalino LP, Cooper J, Crosson FJ, Enthoven A, Falcone E, Feldman RC, Fuchs VR, Garber AM, Gold MR, Goldman D, Hadfield GK, Hall MA, Horwitz RI, Hooven M, Jacobson PD, Jost TS, Kotlikoff LJ, Levin J, Levine S, Levy R, Linscott K, Luft HS, Mashal R, McFadden D, Mechanic D, Meltzer D, Newhouse JP, Noll RG, Pietzsch JB, Pizzo P, Reischauer RD, Rosenbaum S, Sage W, Schaeffer LD, Sheen E, Silber BM, Skinner J, Shortell SM, Thier SO, Tunis S, Wulsin L, Yock P, Nun GB, Bryan S, Luxenburg O, van de Ven WP. Ann Intern Med. 2009; 150 (7): 493-5
• Is having more preapproval data the best way to assure drug safety? Garber AM, Health Aff (Millwood). 2008 Sep-Oct; 27 (5): w371-3
• A menu without prices. Garber AM, Ann Intern Med. 2008; 148 (12): 964-6
• Commentary: the impact of Medicare coverage policies on health care utilization. Garber AM, Health Serv Res. 2008; 43 (4): 1302-7
• Future costs and the future of cost-effectiveness analysis. Garber AM, Phelps CE. J Health Econ. 2008; 27 (4): 819-21
• Is American health care uniquely inefficient? Garber AM, Skinner J. J Econ Perspect. 2008; 22 (4): 27-50
• Management of acute kidney injury in the intensive care unit: a cost-effectiveness analysis of daily vs alternate-day hemodialysis. Desai AA, Baras J, Berk BB, Nakajima A, Garber AM, Owens D, Chertow GM. Arch Intern Med. 2008; 168 (16): 1761-7
• Simple counts of ADL dependencies do not adequately reflect older adults' preferences toward states of functional impairment. Sims T, Holmes TH, Bravata DM, Garber AM, Nelson LM, Goldstein MK. J Clin Epidemiol. 2008; 61 (12): 1261-70
• Systematic review: the effects of growth hormone on athletic performance. Liu H, Bravata DM, Olkin I, Friedlander A, Liu V, Roberts B, Bendavid E, Saynina O, Salpeter SR, Garber AM, Hoffman AR. Ann Intern Med. 2008; 148 (10): 747-58
• Unsupervised method for automatic construction of a disease dictionary from a large free text collection. Xu R, Supekar K, Morgan A, Das A, Garber A. AMIA Annu Symp Proc. 2008: 820-4
• The promise of health care cost containment. Garber A, Goldman DP, Jena AB. Health Aff (Millwood). 2007 Nov-Dec; 26 (6): 1545-7
• A cost-effectiveness analysis of adjuvant trastuzumab regimens in early HER2/neu-positive breast cancer. Kurian AW, Thompson RN, Gaw AF, Arai S, Ortiz R, Garber AM. J Clin Oncol. 2007; 25 (6): 634-41
• B type natriuretic peptide testing was more cost effective than conventional diagnosis in patients with acute dyspnoea. Shetty K, Garber A. Evid Based Med. 2007; 12 (1): 28
• Extracting subject demographic information from abstracts of randomized clinical trial reports. Xu R, Garten Y, Supekar KS, Das AK, Altman RB, Garber AM. Stud Health Technol Inform. 2007; 129 (Pt 1): 550-4
• Rise of pay for performance: implications for care of people with chronic kidney disease. Desai AA, Garber AM, Chertow GM. Clin J Am Soc Nephrol. 2007; 2 (5): 1087-95
• Systematic review: the safety and efficacy of growth hormone in the healthy elderly. Liu H, Bravata DM, Olkin I, Nayak S, Roberts B, Garber AM, Hoffman AR. Ann Intern Med. 2007; 146 (2): 104-15
• To use technology better. Garber AM, Health Aff (Millwood). 2006 Mar-Apr; 25 (2): w51-3
• Combining text classification and Hidden Markov Modeling techniques for categorizing sentences in randomized clinical trial abstracts. Xu R, Supekar K, Huang Y, Das A, Garber A. AMIA Annu Symp Proc. 2006: 824-8
• Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging. Plevritis SK, Kurian AW, Sigal BM, Daniel BL, Ikeda DM, Stockdale FE, Garber AM. JAMA. 2006; 295 (20): 2374-84
• The cost-effectiveness of therapy with teriparatide and alendronate in women with severe osteoporosis. Liu H, Michaud K, Nayak S, Karpf DB, Owens DK, Garber AM. Arch Intern Med. 2006; 166 (11): 1209-17
• The effect of geriatrics evaluation and management on nursing home use and health care costs: results from a randomized trial. Phibbs CS, Holty JE, Goldstein MK, Garber AM, Wang Y, Feussner JR, Cohen HJ. Med Care. 2006; 44 (1): 91-5
• Invariance and inconsistency in utility ratings. Bravata DM, Nelson LM, Garber AM, Goldstein MK. Med Decis Making. 2005 Mar-Apr; 25 (2): 158-67
• Evidence-based guidelines as a foundation for performance incentives. Garber AM, Health Aff (Millwood). 2005 Jan-Feb; 24 (1): 174-9
• Multimedia quality of life assessment: advances with FLAIR. Sims TL, Garber AM, Miller DE, Mahlow PT, Bravata DM, Goldstein MK. AMIA Annu Symp Proc. 2005: 694-8
• Cost-effectiveness and evidence evaluation as criteria for coverage policy. Garber AM, Health Aff (Millwood). 2004 Jan-Jun: Suppl Web Exclusives W4-284-96
• Health plans' coverage determinations for technology-based interventions: the case of electrical bone growth stimulation. Huang AJ, Gemperli MP, Bergthold L, Singer SS, Garber A. Am J Manag Care. 2004; 10 (12): 957-62
• Cost-effectiveness of bypass surgery versus stenting in patients with multivessel coronary artery disease. Yock CA, Boothroyd DB, Owens DK, Garber AM, Hlatky MA. Am J Med. 2003; 115 (5): 382-9
• Racial disparity in cardiac procedures and mortality among long-term survivors of cardiac arrest. Groeneveld PW, Heidenreich PA, Garber AM. Circulation. 2003; 108 (3): 286-91
• Perinatal screening for group B streptococci: cost-benefit analysis of rapid polymerase chain reaction. Haberland CA, Benitz WE, Sanders GD, Pietzsch JB, Yamada S, Nguyen L, Garber AM. Pediatrics. 2002; 110 (3): 471-80
• Quality of life assessment software for computer-inexperienced older adults: multimedia utility elicitation for activities of daily living. Goldstein MK, Miller DE, Davies S, Garber AM. Proc AMIA Symp. 2002: 295-9
• Trends in hospital treatment of ventricular arrhythmias among Medicare beneficiaries, 1985 to 1995. McDonald KM, Hlatky MA, Saynina O, Geppert J, Garber AM, McClellan MB. Am Heart J. 2002; 144 (3): 413-21
• Utilization and outcomes of the implantable cardioverter defibrillator, 1987 to 1995. Hlatky MA, Saynina O, McDonald KM, Garber AM, McClellan MB. Am Heart J. 2002; 144 (3): 397-403
• Evidence-based coverage policy. Garber AM, Health Aff (Millwood). 2001 Sep-Oct; 20 (5): 62-82
• Cost-effectiveness of automated external defibrillators on airlines. Groeneveld PW, Kwong JL, Liu Y, Rodriguez AJ, Jones MP, Sanders GD, Garber AM. JAMA. 2001; 286 (12): 1482-9
• A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease. Gerson LB, Robbins AS, Garber A, Hornberger J, Triadafilopoulos G. Am J Gastroenterol. 2000; 95 (2): 395-407
• Realistic rigor in cost-effectiveness methods. Garber AM, Med Decis Making. 1999 Oct-Dec; 19 (4): 378-9; discussion 383-4
• Cost-effectiveness of alternative test strategies for the diagnosis of coronary artery disease. Garber AM, Solomon NA. Ann Intern Med. 1999; 130 (9): 719-28
• Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A cost-effectiveness analysis. Gould MK, Dembitzer AD, Sanders GD, Garber AM. Ann Intern Med. 1999; 130 (10): 789-99
• Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials. Gould MK, Dembitzer AD, Doyle RL, Hastie TJ, Garber AM. Ann Intern Med. 1999; 130 (10): 800-9
• The effect of search procedures on utility elicitations. Lenert LA, Cher DJ, Goldstein MK, Bergen MR, Garber A. Med Decis Making. 1998 Jan-Mar; 18 (1): 76-83
• Cost-effectiveness and cost-benefit analysis of using methotrexate vs Goeckerman therapy for psoriasis. A pilot study. Chen S, Shaheen A, Garber A. Arch Dermatol. 1998; 134 (12): 1602-8
• Persistence of Medicare expenditures among elderly beneficiaries Garber AM,, MaCurdy TE, McClellan MA.. Frontiers in Health Policy Research I, MIT Press. 1998
• Cholesterol screening guidelines. Consensus, evidence, and common sense. Garber AM, Browner WS. Circulation. 1997; 95 (6): 1642-5
• Cholesterol screening should be targeted. Garber AM, Am J Med. 1997; 102 (2A): 26-30
• Economic foundations of cost-effectiveness analysis. Garber AM, Phelps CE. J Health Econ. 1997; 16 (1): 1-31
• Health care productivity. Brookings Papers on Economic Activity Garber AM., Baily MN,. Microeconomics. 1997: 143-202,
• Measurement of the validity of utility elicitations performed by computerized interview. Lenert LA, Morss S, Goldstein MK, Bergen MR, Faustman WO, Garber AM. Med Care. 1997; 35 (9): 915-20
• Mortality, hospital admissions, and medical costs of end-stage renal disease in the United States and Manitoba, Canada. Hornberger JC, Garber AM, Jeffery JR. Med Care. 1997; 35 (7): 686-700
• Willingness-to-pay utility assessment: feasibility of use in normative patient decision support systems. Flowers CR, Garber AM, Bergen MR, Lenert LA. Proc AMIA Annu Fall Symp. 1997: 223-7
• Cholesterol screening in asymptomatic adults, revisited. Part 2. Garber AM, Browner WS, Hulley SB. Ann Intern Med. 1996; 124 (5): 518-31
• Evaluating the federal role in financing health-related research. Garber AM, Romer PM. Proc Natl Acad Sci U S A. 1996; 93 (23): 12717-24
• The cost of VA-sponsored research. Barnett PG, Garber AM. Acad Med. 1996; 71 (10): 1074-8
• Developing and testing a multimedia presentation of a health-state description. Goldstein MK, Clarke AE, Michelson D, Garber AM, Bergen MR, Lenert LA. Med Decis Making. 1994 Oct-Dec; 14 (4): 336-44
• Is high-flux dialysis cost-effective? Hornberger JC, Garber AM, Chernew ME. Int J Technol Assess Health Care. 1993; 9 (1): 85-96
• A multivariate analysis of mortality and hospital admissions with high-flux dialysis. Hornberger JC, Chernew M, Petersen J, Garber AM. J Am Soc Nephrol. 1992; 3 (6): 1227-37
• Creating the costliest orphan. The Orphan Drug Act in the development of Ceredase. Goldman DP, Clarke AE, Garber AM. Int J Technol Assess Health Care. 1992; 8 (4): 583-97
• Costs and benefits of prenatal screening for cystic fibrosis. Garber AM, Fenerty JP. Med Care. 1991; 29 (5): 473-89
• Costs and health consequences of cholesterol screening for asymptomatic older Americans. Garber AM, Littenberg B, Sox HC, Wagner JL, Gluck M. Arch Intern Med. 1991; 151 (6): 1089-95
• Practice guidelines and cholesterol policy. Garber AM, Wagner JL. Health Aff (Millwood). 1991; 10 (2): 52-66
• The new technology assessment. Fuchs VR, Garber AM. N Engl J Med. 1990; 323 (10): 673-7
• A discrete-time model of the acquisition of antibiotic-resistant infections in hospitalized patients. Garber AM, Biometrics. 1989; 45 (3): 797-816
• Screening asymptomatic adults for cardiac risk factors: the serum cholesterol level. Garber AM, Sox HC, Littenberg B. Ann Intern Med. 1989; 110 (8): 622-39
• The resting electrocardiogram as a screening test. A clinical analysis. Sox HC, Garber AM, Littenberg B. Ann Intern Med. 1989; 111 (6): 489-502
• The role of exercise testing in screening for coronary artery disease. Sox HC, Littenberg B, Garber AM. Ann Intern Med. 1989; 110 (6): 456-69
• Where to draw the line against cholesterol. Garber AM, Ann Intern Med. 1989; 111 (8): 625-7
• Cost-containment and financing the long-term care of the elderly. Garber AM, J Am Geriatr Soc. 1988; 36 (4): 355-61
• Antibiotic exposure and resistance in mixed bacterial populations. Garber AM, Theor Popul Biol. 1987; 32 (3): 326-46